Dawnrays Pharmaceutical (Holdings) Limited
Research Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) on Bullrun: market cap HKD 1.42B, P/E 5.5, dividend yield 6.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2348.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 1.42B
- P/E5.5
- Dividend yield6.6%
- Financial periodFY2025
- RevenueCNY 1.23B
- Revenue growth16.1%
- Net incomeCNY 213.97M
- Free cash flowCNY 236.01M
- Gross margin49.7%
Valuation Snapshot
latest market cap is HKD 1.42B; P/E is 5.5; dividend yield is 6.6%.
Peer valuation comparison
Latest P/E is 5.53x versus a Healthcare sector median of 21.69x (74.5% below).
Latest dividend yield is 6.63% versus a Healthcare sector median of 2.41% (175.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.23B | CNY 213.97M | CNY 236.01M | 49.7% | 0.14 | CNY 1.17B | CNY 77.48M | CNY 3.39B |
| FY2024 | CNY 1.06B | CNY 564.94M | CNY 44.58M | 54.5% | 0.38 | CNY 1.16B | CNY 34.72M | CNY 3.32B |
| FY2023 | CNY 1.15B | CNY 326.00M | CNY 126.39M | 55.7% | 0.22 | CNY 905.83M | CNY 120.53M | CNY 2.85B |
| FY2022 | CNY 1.28B | CNY 358.06M | CNY 208.60M | 60.5% | 0.24 | CNY 811.68M | CNY 8.41M | CNY 2.64B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.42B | 5.5 | 6.7% | 0.06 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.06 HKD, yield 6.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.1 CNY |
| FY2024 | 0.08 CNY |
| FY2023 | 0.09 CNY |
| FY2022 | 0.08 CNY |
| FY2021 | 0.12 CNY |
About Dawnrays Pharmaceutical (Holdings) Limited
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dawnrays Pharmaceutical (Holdings) Limited's market cap?
Dawnrays Pharmaceutical (Holdings) Limited's market capitalization is HKD 1.42B.
What is Dawnrays Pharmaceutical (Holdings) Limited's P/E ratio?
Dawnrays Pharmaceutical (Holdings) Limited's price-to-earnings (P/E) ratio is 5.5.
Does Dawnrays Pharmaceutical (Holdings) Limited pay a dividend?
Dawnrays Pharmaceutical (Holdings) Limited has a dividend yield of 6.6%.
What does Dawnrays Pharmaceutical (Holdings) Limited do?
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics.